SG
RMD icon

StoneX Group’s ResMed RMD Stock Holding History

StoneX Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,395
Closed -$313K – 1552
2026
Q1 		$313K Buy
+1,395
New +$348K 0.02% 556

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

StoneX Group's RMD Position: Q2 2026 in Review

StoneX Group sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,395 shares — an estimated $313K sold.

StoneX Group first reported a position in RMD in Q1 2026 and held it in 1 quarter. The position peaked at $313K in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • StoneX Group reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • StoneX Group sold 1,395 ResMed shares in Q2 2026, an estimated $313K.
  • StoneX Group first reported a position in ResMed in Q1 2026 and held it in 1 quarter.
  • StoneX Group's ResMed position peaked at $313K in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.